Merck in talks to buy biotech Revolution Medicines, FT reports
Group 1 - Merck is in discussions to acquire Revolution Medicines, a company focused on developing cancer drugs [1]
Group 1 - Merck is in discussions to acquire Revolution Medicines, a company focused on developing cancer drugs [1]